Login  |  Register

AstraZeneca and Lilly receive FDA Fast Track designation ...

AstraZeneca and Lilly receive FDA Fast Track designation for AZD3293, an investigational treatment for early Alzheimer’s disease

Alexa Traffic


Listing Links